Concepts (70)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Azithromycin | 10 | 2021 | 3943 | 0.90 | Why? |
| Microtubule-Associated Proteins | 3 | 2017 | 187 | 0.65 | Why? |
| Hydroxychloroquine | 10 | 2021 | 12447 | 0.61 | Why? |
| Vinblastine | 1 | 2013 | 48 | 0.53 | Why? |
| Tyrosine | 1 | 2013 | 66 | 0.51 | Why? |
| Microtubules | 3 | 2017 | 47 | 0.47 | Why? |
| Glioblastoma | 1 | 2013 | 187 | 0.42 | Why? |
| Cell Movement | 1 | 2013 | 695 | 0.39 | Why? |
| Endothelial Cells | 1 | 2013 | 2048 | 0.24 | Why? |
| Drug Interactions | 4 | 2021 | 1653 | 0.22 | Why? |
| Drug Therapy, Combination | 5 | 2021 | 7268 | 0.22 | Why? |
| Anti-Bacterial Agents | 4 | 2021 | 10083 | 0.22 | Why? |
| Antiviral Agents | 7 | 2021 | 41703 | 0.21 | Why? |
| Dose-Response Relationship, Drug | 2 | 2021 | 3776 | 0.18 | Why? |
| DNA, Bacterial | 1 | 2001 | 835 | 0.17 | Why? |
| Carrier Proteins | 1 | 2017 | 513 | 0.13 | Why? |
| Drug Synergism | 3 | 2021 | 833 | 0.13 | Why? |
| Mycobacterium tuberculosis | 1 | 2001 | 1164 | 0.12 | Why? |
| Polymerase Chain Reaction | 3 | 2020 | 6740 | 0.11 | Why? |
| Leukocytes, Mononuclear | 1 | 2001 | 2115 | 0.11 | Why? |
| Human Umbilical Vein Endothelial Cells | 1 | 2013 | 286 | 0.11 | Why? |
| Hyperkalemia | 2 | 2021 | 140 | 0.10 | Why? |
| Vascular Endothelial Growth Factor A | 1 | 2013 | 604 | 0.09 | Why? |
| Hypokalemia | 2 | 2021 | 195 | 0.09 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2017 | 1261 | 0.08 | Why? |
| Long QT Syndrome | 3 | 2021 | 1047 | 0.08 | Why? |
| Drug Combinations | 3 | 2021 | 3852 | 0.08 | Why? |
| Tuberculosis | 1 | 2001 | 2895 | 0.07 | Why? |
| Cell Line, Tumor | 1 | 2013 | 3608 | 0.07 | Why? |
| Antimalarials | 3 | 2021 | 2505 | 0.07 | Why? |
| Models, Biological | 2 | 2017 | 4907 | 0.06 | Why? |
| Electrocardiography | 3 | 2021 | 3957 | 0.06 | Why? |
| France | 3 | 2020 | 12074 | 0.05 | Why? |
| Culture Media | 1 | 2001 | 366 | 0.05 | Why? |
| Magnesium | 1 | 2021 | 290 | 0.04 | Why? |
| Polymerization | 1 | 2017 | 46 | 0.04 | Why? |
| Drug Repositioning | 3 | 2021 | 5683 | 0.04 | Why? |
| Guanosine Triphosphate | 1 | 2017 | 29 | 0.04 | Why? |
| Clinical Trials as Topic | 3 | 2021 | 7330 | 0.04 | Why? |
| Humans | 14 | 2021 | 930598 | 0.04 | Why? |
| Patient Safety | 2 | 2021 | 4885 | 0.04 | Why? |
| Viral Load | 3 | 2020 | 15850 | 0.04 | Why? |
| Protein Stability | 1 | 2017 | 756 | 0.03 | Why? |
| Treatment Outcome | 4 | 2021 | 51732 | 0.03 | Why? |
| Protein Processing, Post-Translational | 1 | 2017 | 634 | 0.03 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.03 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.03 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.03 | Why? |
| Monitoring, Physiologic | 1 | 2021 | 1956 | 0.02 | Why? |
| Pilot Projects | 1 | 2020 | 5182 | 0.02 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.02 | Why? |
| Aged, 80 and over | 3 | 2020 | 88759 | 0.02 | Why? |
| Adult | 5 | 2020 | 244371 | 0.02 | Why? |
| Middle Aged | 5 | 2020 | 270681 | 0.02 | Why? |
| Binding Sites | 1 | 2017 | 6201 | 0.02 | Why? |
| RNA, Viral | 2 | 2021 | 32276 | 0.02 | Why? |
| Male | 5 | 2020 | 367725 | 0.02 | Why? |
| Female | 5 | 2020 | 380317 | 0.01 | Why? |
| Case-Control Studies | 1 | 2001 | 17671 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2020 | 17020 | 0.01 | Why? |
| Nasopharynx | 1 | 2020 | 10224 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2001 | 22971 | 0.01 | Why? |
| Aged | 3 | 2020 | 215776 | 0.01 | Why? |
| Young Adult | 2 | 2020 | 93724 | 0.01 | Why? |
| Models, Theoretical | 1 | 2017 | 6659 | 0.01 | Why? |
| Retrospective Studies | 2 | 2020 | 105322 | 0.01 | Why? |
| Animals | 2 | 2017 | 78931 | 0.01 | Why? |
| Prospective Studies | 1 | 2001 | 43301 | 0.01 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.01 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.01 | Why? |
Honoré's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(70)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(52)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_